Interleukin-1β expression by a recombinant porcine reproductive and respiratory syndrome virus

Virus Research

Volumn 163, Issue 2, 2012, Pages 461-468

  Lawson, Steven R ^a   Li, Yanhua ^a   Patton, John B ^b   Langenhorst, Robert J ^a   Sun, Zhi ^a   Jiang, Zhiyong ^a   Christopher Hennings, Jane ^a   Nelson, Eric A ^a   Knudsen, David ^a   Fang, Ying ^a   Chang, Kyeong Ok ^b  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Cytokine; Interleukin 1 beta; PRRSV; Reverse genetics

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIVIRUS; ARTERIVIRUS INFECTION; ARTICLE; CELL GROWTH; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; FLUOROIMMUNOASSAY; GENE INSERTION; GROWTH RATE; IN VITRO STUDY; IN VIVO STUDY; LETHARGY; NONHUMAN; OPEN READING FRAME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; SWINE DISEASE; UPREGULATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CELL LINE; CYTOKINES; GENE EXPRESSION; INTERLEUKIN-1BETA; LEUKOCYTES, MONONUCLEAR; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; RECOMBINANT PROTEINS; SWINE; VIRAL LOAD; VIRUS REPLICATION;

PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE;

EID: 84856524319     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.11.007     Document Type: Article

References (55)

1. Aasted B., Bach P., Nielsen J., Lind P. Cytokine profiles in peripheral blood mononuclear cells and lymph node cells from piglets infected in utero with porcine reproductive and respiratory syndrome virus. Clin. Diagn. Lab. Immunol. 2002, 9(6):1229-1234.
2. Ahlers J.D., Belyakov I.M., Berzofsky J.A. Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines. Curr. Mol. Med. 2003, 3:285-301.
3. Allende R., Lewis T.L., Lu Z., Rock D.L., Kutish G.F., Ali A., Doster A.R., Osorio F.A. North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions. J. Gen. Virol. 1999, 80:307-315.
4. Andersson U., Tracey K.J. Molecular basis of applied biological therapeutics. J. Intern. Med. 2011, 269:2-7.
5. + T cells. Viral Immunol. 2004, 17:25-37.
6. Bembridge G.P., Lopez J.A., Cook R., Melero J.A., Taylor G. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon. J. Virol. 1998, 72:4080-4087.
7. Bøtner A., Strandbygaard B., Sorensen K.J., Have P., Madsen K.G., Madsen E.S., Alexandersen S. Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet. Rec. 1997, 141:497-499.
8. Boyaka P.N., Tafaro A., Fischer R., Fujihashi K., Jirillo E., McGhee J.R. Therapeutic manipulation of the immune system: enhancement of innate and adaptive mucosal immunity. Curr. Pharm. Des. 2003, 9:1965-1972. (Review).
9. Buddaert W., Van Reeth K., Pensaert M. In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV). Adv. Exp. Med. Biol. 1998, 440:461-467.
10. Bukreyev A., Whitehead S.S., Bukreyeva N., Murphy B.R., Collins P.L. Interferon γ expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2367-2372.
11. Calvert, J.G., Sheppard, M.G., Welch, S.K.W., 2002. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and use thereof. US Patent 6,500,662.
12. Calvert, J.G., Sheppard, M.G., Welch, S.K.W., 2003. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and use thereof. US Patent 20,030,157,689.4.
13. Calvert, J., Sheppard, G., Michael, G., Welch, S.K.W., 2009. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof. US Patent 7618797.
14. Fang Y., Rowland R.R., Roof M., Lunney J.K., Christopher-Hennings J., Nelson E.A. A full-length cDNA infectious clone of North American type 1 porcine reproductive and respiratory syndrome virus: expression of green fluorescent protein in the nsp2 region. J. Virol. 2006, 80:11447-11455.
15. Fang Y., Christopher-Hennings J., Brown E., Liu H., Chen Z., Lawson S., Breen R., Clement T., Gao X., Bao J., Knudsen D., Daly R., Nelson E. Development of genetic markers in the nonstructural protein 2 region of a US type 1 porcine reproductive and respiratory syndrome virus: implications for future recombinant marker vaccine development. J. Gen. Virol. 2008, 89:3086-3096.
16. Flexner C., Moss B., London W.T., Murphy B.R. Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2. Vaccine 1990, 8:17-21.
17. Foss D.L., Zilliox M.J., Meier W., Zuckermann F., Murtaugh M.P. Adjuvant danger signals increase the immune response to porcine reproductive and respiratory syndrome virus. Viral Immunol. 2002, 15:557-566.
18. Gao Y., Daley M.J., Splitter G.A. BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response. Vaccine 1995, 13:871-877.
19. Giavedoni L., Ahmad S., Jones L., Yilma T. Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J. Virol. 1997, 71:866-872.
20. Godson D.L., Baca-Estrada M.E., Van Kessel A.G., Hughes H.P., Morsy M.A., Van Donkersgoed J., Harland R.J., Shuster D.E., Daley M.J., Babiuk L.A. Regulation of bovine acute phase responses by recombinant interleukin-1 beta. Can. J. Vet. Res. 1995, 59:249-255.
21. Halbur P.G., Paul P.S., Frey M.L., Landgraf J., Eernisse K., Meng X.J., Lum M.A., Andrews J.J., Rathje J.A. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet. Pathol. 1995, 32:648-660.
22. Heath A.W., Playfair J.H. Cytokines as immunological adjuvants. Vaccine 1992, 10:427-434. (Review. Erratum in: Vaccine 10, 808).
23. Heegaard P.M., Dedieu L., Johnson N., Le Potier M.F., Mockey M., Mutinelli F., Vahlenkamp T., Vascellari M., Sørensen N.S. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Arch. Virol. 2011, 156:183-202.
24. Karaca K., Sharma J.M., Winslow B.J., Junker D.E., Reddy S., Cochran M., McMillen J. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine 1998, 16:1496-1503.
25. Lawson S., Lunney J., Zuckermann F., Osorio F., Nelson E., Welbon C., Clement T., Fang Y., Wong S., Kulas K., Christopher-Hennings J. Development of an 8-plex Luminex assay to detect swine cytokines for vaccine development: assessment of immunity after porcine reproductive and respiratory syndrome virus (PRRSV) vaccination. Vaccine 2010, 28:5356-5364.
26. Leong K.H., Ramsay A.J., Boyle D.B., Ramshaw I.A. Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J. Virol. 1994, 68:8125-8130.
27. Lunney J.K., Fritz E.R., Reecy J.M., Kuhar D., Prucnal E., Molina R., Christopher-Hennings J., Zimmerman J., Rowland R.R.R. Interleukin-8, interleukin-1β, and interferon-γ levels are linked to PRRS virus clearance. Viral Immunol. 2010, 23:127-134.
28. Martínez-Lobo F.J., Díez-Fuertes F., Segalés J., García-Artiga C., Simarro I., Castro J.M., Prieto C. Comparative pathogenicity of type 1 and type 2 isolates of porcine reproductive and respiratory syndrome virus (PRRSV) in a young pig infection model. Vet. Microbiol. 2011, (Epub ahead of print).
29. Meier W.A., Galeota J., Osorio F.A., Husmann R.J., Schnitzlein W.M., Zuckermann F.A. Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 2003, 309:18-31.
30. Mengeling W.L. The porcine reproductive and respiratory syndrome quandary. Part II: vaccines and vaccination strategy. J. Swine Health Prod. 2005, 13:152-156.
31. Murtaugh M.P., Xiao Z., Zuckermann F. Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection. Viral Immunol. 2002, 15:533-547.
32. Nelsen C.J., Murtaugh M.P., Faaberg K.S. Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J. Virol. 1999, 73:270-280.
33. Overend C., Mitchell R., He D., Rompato G., Grubman M.J., Garmendia A.E. Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2007, 88:925-931.
34. Petrovsky N., Aguilar J.C. Vaccine adjuvants: current state and future trends. Immunol. Cell. Biol. 2004, 82:488-496.
35. Raggo C., Fitzpatrick D.R., Babiuk L.A., Liang X. Expression of bovine interleukin-1β in a bovine herpesvirus-1 vector: in vitro analysis. Virology 1996, 221:78-86.
36. Reddy D.N., Reddy P.G., Minocha H.C., Fenwick B.W., Baker P.E., Davis W.C., Blecha F. Adjuvanticity of recombinant bovine interleukin-1 beta: influence on immunity, infection, and latency in a bovine herpesvirus-1 infection. Lymphokine Res. 1990, 9:295-307.
37. Reddy D.N., Reddy P.G., Xue W., Minocha H.C., Daley M.J., Blecha F. Immuno-potentiation of bovine respiratory disease virus vaccines by interleukin-1 beta and interleukin-2. Vet. Immunol. Immunopathol. 1993, 37:25-38.
38. Rossow K.D. Porcine reproductive and respiratory syndrome. Vet. Pathol. 1998, 35:1-20.
39. Rossow K.D., Collins J.E., Goyal S.M., Nelson E.A., Christopher-Hennings J., Benfield D.A. Pathogenesis of porcine reproductive and respiratory syndrome virus infection in gnotobiotic pigs. Vet. Pathol. 1995, 32:361-373.
40. Royaee A.R., Husmann R., Dawson H.D., Calzada-Nova G., Schnitzlein W.M., Zuckermann F., Lunney J.K. Deciphering the involvement of innate immune factors in the development of the host responses to PRRSV vaccination. Vet. Immunol. Immunopathol. 2004, 102:199-216.
41. Snijder E.J., Meulenberg J.J. The molecular biology of arteriviruses. J. Gen. Virol. 1998, 79:961-979.
42. Somasundaram C., Takamatsu H., Andréoni C., Audonnet J.C., Fischer L., Lefèvre F., Charley B. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus. Vet. Immunol. Immunopathol. 1999, 70:277-287.
43. Spight D., Zhao B., Haas M., Wert S., Denenberg A., Shanley T.P. Immunoregulatory effects of regulated, lung-targeted expression of IL-10 in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 288:L251-L265.
44. Suradhat S., Thanawongnuwech R. Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2003, 84:2755-2760.
45. Suradhat S., Thanawongnuwech R., Poovorawan Y. Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 2003, 84:453-459.
46. Thanawongnuwech R., Thacker E.L. Interleukin-10, interleukin-12, and interferon-gamma levels in the respiratory tract following Mycoplasma hyopneumoniae and PRRSV infection in pigs. Viral Immunol. 2003, 16:357-367.
47. Thanawongnuwech R., Thacker B., Halbur P., Thacker E.L. Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae. Clin. Diagn. Lab. Immunol. 2004, 11:901-908.
48. van Reeth K., Labarque G., Nauwynck H., Pensaert M. Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity. Res. Vet. Sci. 1999, 67:47-52.
49. van Reeth K., van Gucht S., Pensaert M. In vivo studies on cytokine involvement during acute viral respiratory disease of swine: troublesome but rewarding. Vet. Immunol. Immunopathol. 2002, 87:161-168.
50. Wasilk A., Callahan J.D., Christopher-Hennings J., Gay T.A., Fang Y., Dammen M., Reos M.E., Torremorell M., Polson D., Mellencamp M., Nelson E., Nelson W.M. Detection of US, Lelystad, and European-like porcine reproductive and respiratory syndrome viruses and relative quantitation in boar semen and serum samples by real-time PCR. J. Clin. Microbiol. 2004, 42:4453-4461.
51. Yilma T., Verardi P., Jones L. Development of safe and efficacious viral vaccines for animals. Crit. Rev. Immunol. 2010, 30:223-237.
52. Yoon I.J., Joo H.S., Goyal S.M., Molitor T.W. A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera. J. Vet. Diagn. Invest. 1994, 6:289-292.
53. Zeman D., Neiger R., Yaeger M., Nelson E., Benfield D., Leslie-Steen P., Thomson J., Miskimins D., Daly R., Minehart M. Laboratory investigation of PRRS virus infection in three swine herds. J. Vet. Diagn. Invest. 1993, 5:522-528.
54. Zuckermann F.A., Husmann R.J., Schwartz R., Brandt J., Mateu de Antonio E., Martin S. Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine. Vet. Immunol. Immunopathol. 1998, 63:57-67.
55. Zuckermann F.A., Martin S., Husmann R.J., Brandt J. Use of interleukin 12 to enhance the cellular immune response of swine to an inactivated herpesvirus vaccine. Adv. Vet. Med. 1999, 41:447-461. (Review).